The Role of Caspases in Melanoma Pathogenesis.

caspase caspase-3 melanoma pathogenesis

Journal

Current issues in molecular biology
ISSN: 1467-3045
Titre abrégé: Curr Issues Mol Biol
Pays: Switzerland
ID NLM: 100931761

Informations de publication

Date de publication:
28 Aug 2024
Historique:
received: 30 07 2024
revised: 18 08 2024
accepted: 22 08 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 27 9 2024
Statut: epublish

Résumé

Melanoma (malignant melanoma, MM) is an aggressive malignant skin cancer with an increasing incidence rate. The complete pathogenesis of MM in not clear. Due to DNA damage, mutations, dysregulation of growth factors, inactivation of tumor suppressor genes, and activation of oncogenes, excessive uncontrolled growth of abnormal melanocytes occurs in melanomas. Caspases are a group of proteolytic enzymes that participate in several processes important in regulating mechanisms at the cellular level. They play a role in cell homeostasis and programmed cell death (apoptosis) and in the regulation of non-apoptotic cell death processes. Dysregulation of caspase activation plays a role in the etiology of cancers, including melanoma. Caspases can initiate and execute apoptosis and are involved in regulating cell death and controlling tumor growth. These enzymes also inhibit tumor growth by cleaving and inactivating proteins that are involved in cell proliferation and angiogenesis. Moreover, caspases are involved in the activation of immune processes through the processing and presentation of tumor antigens, which facilitates recognition of the tumor by the immune system. The role of caspases in melanoma is complex, and they may inhibit melanoma growth and progression. This work aims to review the current knowledge of the role of individual caspases in melanoma pathogenesis.

Identifiants

pubmed: 39329914
pii: cimb46090562
doi: 10.3390/cimb46090562
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

9480-9492

Auteurs

Agnieszka Szmurło (A)

Department of Dermatology, The National Institute of Medicine of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Department of Dermatology, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland.

Klaudia Dopytalska (K)

Department of Dermatology, The National Institute of Medicine of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Department of Dermatology, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland.

Michał Szczerba (M)

Department of Dermatology, The National Institute of Medicine of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Department of Dermatology, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland.

Elżbieta Szymańska (E)

Department of Dermatology, The National Institute of Medicine of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Department of Dermatology, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland.

Alicja Petniak (A)

Department of Clinical Genetics, Medical University of Lublin, 20-080 Lublin, Poland.

Marcin Kocki (M)

Department of Clinical Genetics, Medical University of Lublin, 20-080 Lublin, Poland.

Janusz Kocki (J)

Department of Clinical Genetics, Medical University of Lublin, 20-080 Lublin, Poland.

Irena Walecka (I)

Department of Dermatology, The National Institute of Medicine of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Department of Dermatology, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland.

Classifications MeSH